Kalbe Farma's Q1 profit up 27%

Wed, 04 May 2005 | Source: AP

JAKARTA: PT Kalbe Farma, Indonesia's biggest drugmaker by sales, said its net income rose 27 percent in the first quarter, boosted by sales of painkillers including Neuralgin and Procold.

Unaudited net income in the three months ended March 31 rose to Rp 159.5 billion (US$17 million), or Rp 19.64 a share, from Rp 125.72 billion, or Rp 15.48 a share, the Bekasi-based Kalbe said in a statement to the Jakarta Stock Exchange on Monday night.

Sales at Kalbe, which makes about a quarter of all non- prescription drugs sold in Indonesia, increased to Rp 1.02 trillion in the three months, from Rp 807.3 billion a year earlier, the statement said.

Kalbe shares fell Rp 10, or 1.4 percent, to Rp 710 on Monday on the Jakarta Stock Exchange. -- Bloomberg

View JSON | Print